RxDoctor Payments Data

Erin Betzner-Potkul

Adult Health · Orange City, FLNPI 1194133728

Payments from drug & device makers

$6,191in general payments, 2019–2025

Across 245 payments — averaging $25.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$935
  • Calliditas Therapeutics US Inc.$692
  • AstraZeneca$654
  • Amgen$483
  • Otsuka America Pharmaceutical, Inc.$407
  • Bayer$381
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$5,93996%
  • Education$2524%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,191 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol43$36,622
JardianceEmpagliflozin15$13,241
Sevelamer Carbonate14$4,268
Calcitriol73$1,686
Losartan Potassium128$1,246
Potassium Chloride48$1,016
Bumetanide33$922
Furosemide113$858
Allopurinol110$786
Amlodipine Besylate94$620
Lisinopril103$548
Hydralazine Hcl30$539
Ondansetron OdtOndansetron11$364
Carvedilol27$271
Spironolactone18$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$654$36,62243 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.

Other adult health in Orange City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →